The positive impact of GLP-2 on proliferation has been shown in many studies [10,41,74,75], while the information on Ki-67 as a proliferation marker in SBS patients is limited. This evidence concerns the gene MKI67 and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.